These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 26406495)

  • 1. Underestimation of plasma level of factor V coagulant activity and fibrinogen concentration together with prolonged prothrombin time, activated partial thromboplastin time and thrombin time can result from pre-analytical very low calcium level in citrated sample tube.
    d'Audigier C; Delassasseigne C; Robert A; Eschwège V
    Int J Lab Hematol; 2016 Feb; 38(1):50-3. PubMed ID: 26406495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-analytical practices for routine coagulation tests in European laboratories. A collaborative study from the European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM).
    Kristoffersen AH; Stavelin AV; Ajzner E; Kristensen GBB; Sandberg S; Van Blerk M; Kitchen S; Kesseler D; Woods TAL; Meijer P
    Clin Chem Lab Med; 2019 Sep; 57(10):1511-1521. PubMed ID: 31085743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism for shortening PT and APTT in dogs and rats--effect of fibrinogen on PT and APTT--.
    Kurata M; Sasayama Y; Yamasaki N; Kitazawa I; Hamada Y; Horii I
    J Toxicol Sci; 2003 Dec; 28(5):439-43. PubMed ID: 14746347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of the anticoagulants argatroban and lepirudin: a comparison of laboratory methods.
    Ivandic B; Zorn M
    Clin Appl Thromb Hemost; 2011 Oct; 17(5):549-55. PubMed ID: 20834029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single-institution retrospective study of causes of prolonged prothrombin time and activated partial thromboplastin time in the outpatient setting.
    Hazim AZ; Ruan GJ; Khodadadi RB; Slusser JP; Marshall AL; Pruthi RK
    Int J Lab Hematol; 2022 Feb; 44(1):209-215. PubMed ID: 34612006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-Specific Reference Intervals for PT, aPTT, Fibrinogen and Thrombin Time for Parturient Women.
    Zhang GM; Zhang W; Zhang GM
    Thromb Haemost; 2019 Jun; 119(6):894-898. PubMed ID: 30934105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of fibrinogen degradation products on thrombin time, activated partial thromboplastin time and prothrombin time of canine plasma.
    Mischke R; Wolling H
    Haemostasis; 2000; 30(3):123-30. PubMed ID: 11014962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory measurements of the oral direct factor Xa inhibitor edoxaban: comparison of prothrombin time, activated partial thromboplastin time, and thrombin generation assay.
    Morishima Y; Kamisato C
    Am J Clin Pathol; 2015 Feb; 143(2):241-7. PubMed ID: 25596250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays.
    Lindahl TL; Baghaei F; Blixter IF; Gustafsson KM; Stigendal L; Sten-Linder M; Strandberg K; Hillarp A;
    Thromb Haemost; 2011 Feb; 105(2):371-8. PubMed ID: 21103660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing the use of coagulation test panels.
    Amukele TK; Baird GS; Chandler WL
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):688-95. PubMed ID: 21934488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of clotting screens.
    Thorell SE; Nash MJ; Thachil J
    Int J Lab Hematol; 2015 Feb; 37(1):8-13. PubMed ID: 24636194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of dabigatran and rivaroxaban on routine coagulation assays. A nationwide Belgian survey.
    Van Blerk M; Bailleul E; Chatelain B; Demulder A; Devreese K; Douxfils J; Jochmans K; Mullier F; Wijns W; Soumali MR; Coucke W; Vernelen K; Van de Walle P
    Thromb Haemost; 2015 Jan; 113(1):154-64. PubMed ID: 25231101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the minimal citrate tube fill volume for routine coagulation tests on ACL TOP 500 CTS®.
    Ver Elst K; Vermeiren S; Schouwers S; Callebaut V; Thomson W; Weekx S
    Int J Lab Hematol; 2013 Dec; 35(6):614-9. PubMed ID: 23663653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitfalls in the assessment of disseminated intravascular coagulation in patients on dabigatran.
    Kanda GS; Ho WK; Rodrigues C; Bousounis A; Hogan C
    Pathology; 2021 Aug; 53(5):623-627. PubMed ID: 33526243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tigecycline treatment causes a decrease in fibrinogen levels.
    Zhang Q; Zhou S; Zhou J
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1650-5. PubMed ID: 25547356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aqueous extract from Brownea grandiceps flowers with effect on coagulation and fibrinolytic system.
    Pereira B; Brazón J
    J Ethnopharmacol; 2015 Feb; 160():6-13. PubMed ID: 25460592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference of M-protein on prothrombin time test - case report.
    Margetić S; Ćelap I; Dukić L; Vukasović I; Virović-Jukić L
    Biochem Med (Zagreb); 2016; 26(2):248-54. PubMed ID: 27346971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining the maximal storage time of centrifuged citrated samples for performing add-on routine coagulation tests.
    Denessen EJS; Jeurissen MLJ; Pereboom RMTA; Verhezen PWM; Henskens YMC
    Thromb Res; 2020 Dec; 196():54-62. PubMed ID: 32841921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of temperature and time before centrifugation of specimens for routine coagulation testing.
    Salvagno GL; Lippi G; Montagnana M; Franchini M; Poli G; Guidi GC
    Int J Lab Hematol; 2009 Aug; 31(4):462-7. PubMed ID: 18371059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of 8 and 24-h storage of whole blood at ambient temperature on prothrombin time, activated partial thromboplastin time, fibrinogen, thrombin time, antithrombin and D-dimer.
    Kemkes-Matthes B; Fischer R; Peetz D
    Blood Coagul Fibrinolysis; 2011 Apr; 22(3):215-20. PubMed ID: 21297453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.